Robert Hawkins
Manchester University
H-index: 83
North America-United States
Top articles of Robert Hawkins
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Receptors providing targeted costimulation for adoptive cell therapy | 2023/7/20 | ||
Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons | Nature Biomedical Engineering | Wenchao Gu Sijin Luozhong Simian Cai Ketaki Londhe Nadine Elkasri | 2024/2/19 |
Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignancies | EJHaem | Kyrillus S Shohdy Manon Pillai Ryan Guest Dominic Rothwell Natalia Kirillova | 2023/8 |
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor … | Frontiers in Immunology | Milena Kalaitsidou Owen R Moon Martina Sykorova Leyuan Bao Yun Qu | 2023/11/7 |
423 Single cell RNA sequencing reveals functionally validated signatures of cytotoxicity in anti-FRα CoStimulatory Antigen Receptor (CoStARTM) activated CD4+ T cells | Katrina Sherbina Baklan Martina Sykorova Leyuan Bao Owen Moon Robert E Hawkins | 2023/11/1 | |
426 Anti-folate receptor alpha (FRα) CoStimulatory Antigen Receptor (CoStAR™) drives distinct cytokine-mediated proliferation responses in CD4+ and CD8+ T cells | Martina Sykorova Robert E Hawkins Mark Dudley Gray Kueberuwa John S Bridgeman | 2023/11/1 | |
Chimeric molecules providing targeted costimulation for adoptive cell therapy | 2023/10/19 | ||
Engineering strategies to optimise adoptive cell therapy in ovarian cancer | Catarina Guerra Milena Kalaitsidou Gray Kueberuwa Robert Hawkins Richard Edmondson | 2023/10/5 | |
Acute and chronic cardiopulmonary effects of high dose interleukin-2 therapy: an observational magnetic resonance imaging study | Diagnostics | Jakub Lagan Josephine H Naish Christien Fortune Christopher Campbell Shien Chow | 2022/5/30 |
Clinical feasibility and treatment outcomes with nonselected autologous tumor-infiltrating lymphocyte therapy in patients with advanced cutaneous melanoma | American journal of cancer research | Manon Pillai Yizhou Jiang Paul C Lorigan Fiona C Thistlethwaite Martine Thomas | 2022 |
Clinical feasibility and treatment outcomes with unselected autologous tumor infiltrating lymphocyte therapy in patients with advanced cutaneous melanoma | Cancer Res | Robert E Hawkins Yizhou Jiang Paul C Lorigan Fiona C Thistlethwaite Manon Pillai | 2021/7/1 |
177 Treatment outcomes with unselected autologous tumor infiltrating lymphocytes in patients with checkpoint inhibition–refractory advanced cutaneous melanoma | Journal for ImmunoTherapy of Cancer | Robert Hawkins Yizhou Jiang Paul C Lorigan Fiona C Thistlethwaite Manon Pillai | 2021/11/1 |
Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma | Clinical Cancer Research | Andrew J Armstrong Andrew B Nixon Andrea Carmack Qian Yang Tim Eisen | 2021/6/15 |
199 Potent T cell costimulation mediated by a novel costimulatory antigen receptor (CoStAR) with dual CD28/CD40 signaling domains to improve adoptive cell therapies | Journal for ImmunoTherapy of Cancer | Martina Sykorova Leyuan Bao Cynthia Chauvin-Fleurence Milena Kalaitsidou Michelle Le Brocq | 2021/11/1 |
Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma | Clinical Cancer Research | Andrew J Armstrong Andrew B Nixon Andrea Carmack Qian Yang Tim Eisen | 2021/6/15 |
Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial | Kidney cancer journal: official journal of the Kidney Cancer Association | Susan Halabi Qian Yang Andrea Carmack Shiqi Zhang Wen-Chi Foo | 2021/10 |
Atezolizumab plus bevacizumab versus sunitinib for patients with untreated metastatic renal cell carcinoma and sarcomatoid features: a prespecified subgroup analysis of the … | European urology | Brian I Rini Robert J Motzer Thomas Powles David F McDermott Bernard Escudier | 2021/5/1 |
A phase I/II study to assess the safety and efficacy of pazopanib and pembrolizumab combination therapy in patients with advanced renal cell carcinoma | Clinical genitourinary cancer | Simon Chowdhury Jeffery R Infante Robert Hawkins Martin H Voss Rodolfo Perini | 2021/10/1 |
Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma | Cells | Stephane Oudard Nadine Benhamouda Bernard Escudier Patrice Ravel Thi Tran | 2021/12/22 |
Angiokines associated with outcomes after sunitinib or everolimus treatment in patients with non-clear cell renal cell carcinoma | Clinical Cancer Research | Andrew J Armstrong Andrew B Nixon Andrea Carmack Tim Eisen Walter M Stadler | 2021 |
